Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Pediatrics Education and Research

Volume  11, Issue 1, January – April 2023, Pages 27-31
 

Case Report

Reactivation at BCG Vaccination Site in a Case of Multisystem Inflammatory Syndrome in Children

Praveen Unki , Sujay Rangaswamy , Sri Raksha Satya , Shreyas Vishwanath

Assistant Professor, Topiwala National Medical College, Mumbai 400008, Maharashtra, India, Senior Resident, Assistant Professor, Junior Resident, Department of Pediatrics, Adichunchanagiri Institute of Medical Sciences, Mandya 571448, Karnataka, India

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: https://dx.doi.org/10.21088/per.2321.1644.11123.4

Abstract

Background: Kawasaki disease is a well known entity in pediatric age group and so is its counterpart Multisystem Inflammatory Syndrome in Children (MIS-C). MIS-C term became more popular during covid era as the infection started to affect pediatric age group. Now, a large number pediatricians have seencases of MIS-C. Reactivation of BCG scar is less commonly seen in Kawasaki disease and rare to never in a case of MIS-C. Case Presentation: We report a 6-month-old male child who presented with cold and fever. Covid Rapid Antigen Test (RAT) and Covid RTPCR were negative. He continued to have high grade feverwhich is unusual for a case of bronchiolitis and started on antibiotics. Clinical suspicion of MIS-C made and started to work up for the same. Examination revealed reactivation at BCG site with pealing of skin. Further investigations showed elevated CRP and d-dimer with positive anti-SARS COV2 antibody. Diagnosis of MIS-C confirmed and treated with methylprednisolone and IVIG. Conclusion: Reactivation at BCG site is well known entity in Kawasaki disease and as a post vaccination immune cross reactivity. But never reported in a case of MIS-C as less known abouthuman immunological response towards Covid-19 infection and its sequel. It can be considered as an early diagnostic tool in resource poor settings and at community level.


Keywords : Multisystem Inflammatory Syndrome in Children; BCG scar; IVIG; Methylprednisolone.
Corresponding Author : Praveen Unki, Assistant Professor, Department of Pediatrics, Topiwala National Medical College, Mumbai-400008, Karnataka, India.